EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Martina Berto Tbk (MBTO) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of Martina Berto Tbk IDR 224, price IDR 153, upside +46.4%, quality 48 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? No
  3. Add to watchlist

Consumer Defensive · ID · ISIN ID1000118102

MB Thin data Sep 24, 2026

Martina Berto Tbk

MBTO · JK

SpeculativeUpside exists, but weak quality makes the signal speculative.

✓Fair value 223.93 IDR · Undervalued (+46%)
!Quality 48/100
!Mixed Growth (revenue 5y +6.2 %/yr)
!Loss-making · -3.1% net margin (TTM)
✓Low debt · generates free cash flow
!Mixed vs. peers (5/9)
!Narrow moat 29/100
!Evidence only low, so the estimate is less certain

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

334.00 IDR 60.00 IDR Fair Value 223.93 IDR Apr 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 60.00 IDR – 334.00 IDR · fair‑value band 188.48 IDR – 285.07 IDR · the 153.00 IDR price screens below the 223.93 IDR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Martina Berto Tbk in your weekly email

Every Wednesday you see whether Martina Berto Tbk is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

PT Martina Berto Tbk, together with its subsidiaries, manufactures, markets, sells, and trades in cosmetics and traditional medicines in Indonesia and internationally. It operates in two segments, Cosmetics and Herbal Medicine.

Show more

PT Martina Berto Tbk, together with its subsidiaries, manufactures, markets, sells, and trades in cosmetics and traditional medicines in Indonesia and internationally. It operates in two segments, Cosmetics and Herbal Medicine. The company offers facial cleansers, toners, moisturizers, liquid foundations, body splash colognes, hair sprays, and other liquid formulations; eye shadow, blush on, loose powder, compact powder, and other powder-based products; lipsticks, creamy foundations, and other semi-solid formulations; and masks, body scrubs, herbal teas, and mangir and other natural-based products. It sells its products under the Sariayu Martha Tilaar, Dewi Sri Spa Martha Tilaar, Biokos Martha Tilaar, Caring Colours by Martha Tilaar, Martha Tilaar Professional Artist Cosmetics, Belia Martha Tilaar, Rudy Hadisuwarno Cosmetics, Mirabella, and Cempaka brands. PT Martina Berto Tbk was founded in 1977 and is headquartered in Jakarta, Indonesia. PT Martina Berto Tbk operates as a subsidiary of PT Marthana Megahayu Inti.

Stock analysis

Martina Berto Tbk (MBTO) currently trades at 153.00 IDR, while our model-based Fair Value estimate is 223.93 IDR, implying the stock looks roughly 31.7% undervalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of 235.91 IDR per share, and 9 of the 10 models we run sit above the 153.00 IDR price.

Bear case: the Multiples group reads lowest at 144.43 IDR, and 1 of the 10 models stay below the price. Evidence for this calculation is low.

Scenario range: 188.48 IDR (bear) to 285.07 IDR (bull), the price of 153.00 IDR sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 48/100 (below-average quality), in the Consumer Defensive sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Martina Berto Tbk reported revenue of 402B IDR in FY2025 versus 211B IDR in FY2021, a compound +17.5%/yr. Reported net income was −27.8B IDR in FY2025.

Key figures

Market cap 164B IDR (≈ $9.1M) · P/S ratio 0.30 · EPS (TTM) −120.73 IDR · Net margin −6.9% · Return on equity −3.7% · Return on assets (EBIT) −2.9% · Operating margin 13.2% · Revenue (TTM) 423B IDR.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 46 out of 100 (low confidence).

What moves the price

The share trades about 54% below its 52-week high and 61% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at −14% fair-value upside, at 46%, MBTO screens cheaper than that median.

Fair Value models

Bear 188.48 IDR Fair Value 223.93 IDR Bull 285.07 IDR
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF 258.90 IDR 345.36 IDR 509.20 IDR 81
Growth DCF 268.77 IDR 352.59 IDR 498.28 IDR 79
5Y EBITDA Exit 159.45 IDR 204.36 IDR 265.73 IDR 76
All 10 models by family
DCF Models
FCF DCF 258.90 IDR 345.36 IDR 509.20 IDR 81
5Y Revenue Exit 173.67 IDR 228.66 IDR 310.42 IDR 73
5Y EBITDA Exit 159.45 IDR 204.36 IDR 265.73 IDR 76
10Y Revenue Exit 202.82 IDR 251.16 IDR 302.52 IDR 68
10Y EBITDA Exit 197.50 IDR 235.91 IDR 275.41 IDR 70
Multiples
EV/EBITDA 109.45 IDR 144.43 IDR 179.41 IDR 67
EV/Revenue 127.94 IDR 180.84 IDR 233.74 IDR 54
Asset-Based
NCAV (Graham) 158.68 IDR 212.63 IDR 317.36 IDR 54
Growth DCF
Growth DCF 268.77 IDR 352.59 IDR 498.28 IDR 79
Rev-Margin DCF 173.67 IDR 234.71 IDR 313.56 IDR 73

Open the full fair value analysis →

Notify me when MBTO reaches fair value

Put MBTO on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 48/100

Of which business quality 46 · Market factors (momentum, volatility) 52

Profitability 17
Margins and returns on capital today
Quality Growth 19
Are margins and returns improving?
Cashflow 43
Earnings quality: real cash, not paper profit
Fin. Strength 45
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 65
Price trend over the last 3–12 months (market factor)
52W Momentum 33
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 38/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−7.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.2%
Start year 2020 (pandemic). Over 10 years: −5.3% a year
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.0%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−56.0% (2020) → −1.0% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+0.7%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Indonesia: IMF forecast 2.6% a year to 2030, 2.9% from 2016 to 2025) that is about −1.9% a year for the price.

Watch MBTO, get fair value alerts →

Compare Martina Berto Tbk with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 251 stocks

Beats the industry median on 4/7 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 48 · Below median
Fair Value upside +45% · Top 25%
Profitability
Return on assets 1% · Below median
Net margin (TTM) −3% · Bottom 25%
Operating margin (TTM) 13% · Above median
Growth and dividend
Revenue growth 24% · Top 25%

Valuation Multiplesvs Household & Personal Products median · lower = cheaper

P/FCF 0.0× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)95 · sector 33
FUTURE (revenue growth)100 · sector 5
PAST (return on equity)0 · sector 27
HEALTH (low debt)100 · sector 98
DIVIDEND (yield)0 · sector 55

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Colgate-Palmolive Company CL $85.93 $55.95 −35%
Hindustan Unilever Limited HINDUNILVR ₹1,950 ₹775.25 −60%
Kenvue Inc KVUE $17.86 $12.73 −29%
Kimberly-Clark Corporation KMB $97.70 $83.93 −14%
Henkel AG HEN €68.50 €80.96 +18%
The Estée Lauder Companies Inc EL $98.83 $27.22 −72%
Church & Dwight Co CHD $96.02 $65.12 −32%
Beiersdorf Aktiengesellschaft, BEI €78.18 €68.95 −12%
Puig Brands, S.A PUIG €17.56 €19.32 +10%
The Clorox Company CLX $87.15 $104.53 +20%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Martina Berto Tbk Fair Value". https://www.fairvalue-calculator.com/stock/MBTO

Frequently asked questions

Is Martina Berto Tbk (MBTO) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 223.93 IDR versus a price of 153.00 IDR, about +46% upside (undervalued).
What is the fair value of MBTO?
Our model-based fair value for Martina Berto Tbk is 223.93 IDR (as of Sep 24, 2026), built from audited fundamentals. The current price: 153.00 IDR.
What is the quality score of MBTO?
Martina Berto Tbk has a Quality Score of 48/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Martina Berto Tbk (MBTO)?
Our model-based price target is the fair value of 223.93 IDR (as of Sep 24, 2026) from 10 valuation models. Cautious scenario 188.48 IDR, optimistic scenario 285.07 IDR. It is a calculation from audited fundamentals, not an analyst target.
What is the Martina Berto Tbk stock forecast for 2026?
Our models put fair value at 223.93 IDR, about +46% upside versus a price of 153.00 IDR (undervalued). Cautious scenario 188.48 IDR, optimistic scenario 285.07 IDR. The calculation is refreshed regularly with new filings.
What is the revenue of Martina Berto Tbk (MBTO)?
Martina Berto Tbk reported trailing-twelve-month revenue of about 423B IDR (latest available figure, as of Sep 24, 2026).
What growth is priced into Martina Berto Tbk (MBTO)?
For today's price to be fair in a discounted-cash-flow model, Martina Berto Tbk would have to grow free cash flow by +0.7 % per year for five years (discount rate 10.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +6.2 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of MBTO use?
Our models discount Martina Berto Tbk at 10.5 %: a base by market capitalisation (nano), damped by beta 0.37, country premium for Indonesia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Martina Berto Tbk that is +0.7 % per year a year over ten years, using the same discount rate (10.5 %) and the same formula as our fair value.
How much growth has Martina Berto Tbk (MBTO) delivered so far?
Over the past 5 years revenue at Martina Berto Tbk grew +6.2 % a year. The price currently implies +0.7 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Martina Berto Tbk (MBTO) growing?
The median revenue growth in the sector is +2.9 % a year. That is the yardstick for the growth priced into Martina Berto Tbk (+0.7 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Martina Berto Tbk (MBTO)?
The free-cash-flow yield on the price is 8.87 %: that much free cash flow Martina Berto Tbk produces per unit of market value. When it exceeds the discount rate of our models (10.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Martina Berto Tbk (MBTO)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Martina Berto Tbk it is 223.93 IDR per share (as of Sep 24, 2026), against a price of 153.00 IDR. It is the blended result of 10 valuation models (cash flow, earnings, asset, dividend).
Is Martina Berto Tbk stock overvalued or undervalued in 2026?
As of Sep 24, 2026, MBTO trades below its calculated fair value: price 153.00 IDR, fair value 223.93 IDR, a gap of about +46% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MBTO?
No. The price is what the market pays today (153.00 IDR); the fair value is what the company's own numbers justify (223.93 IDR). For Martina Berto Tbk the two are 70.93 IDR per share apart. That gap is exactly why we show both numbers side by side.
How much is Martina Berto Tbk worth?
The market values Martina Berto Tbk at about 164B IDR (market capitalisation, as of Sep 24, 2026). Per share that is 153.00 IDR; our models calculate a fair value of 223.93 IDR per share.
What do the bullish and bearish scenarios say about MBTO?
Our models span a range for Martina Berto Tbk: cautious scenario 188.48 IDR, base 223.93 IDR, optimistic 285.07 IDR per share (as of Sep 24, 2026, price 153.00 IDR). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Martina Berto Tbk (MBTO)?
Balance-sheet figures for Martina Berto Tbk (as of Sep 24, 2026): return on equity −3.7%. They feed the Quality Score of 48/100, which measures business quality independently of the share price.
How far is MBTO from its 52-week high?
Martina Berto Tbk trades at 153.00 IDR, about 54% below its 52-week high of 334.00 IDR and 61% above the low of 95.00 IDR (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 223.93 IDR is for.
Which stocks are comparable to Martina Berto Tbk?
From the same area (Consumer Defensive) we also value Colgate-Palmolive Company, Hindustan Unilever Limited, Kenvue Inc, Kimberly-Clark Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Martina Berto Tbk stock attractive at the current price?
The data as of Sep 24, 2026: price 153.00 IDR, calculated fair value 223.93 IDR (+46%), Quality Score 48/100, from 10 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MBTO calculated?
We run Martina Berto Tbk through 10 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 223.93 IDR, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Martina Berto Tbk currently trades 46 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Martina Berto Tbk (MBTO)?
The closing price on Sep 24, 2026 was 153.00 IDR. Our model-based fair value is 223.93 IDR, about +46% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Martina Berto Tbk right now?
The price is below even our cautious bear case (188.48 IDR). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (48/100) at a price below fair value, the discount is the argument here, not the business quality.

Key figures of Martina Berto Tbk

How large is the market capitalisation of Martina Berto Tbk (MBTO)?
The market capitalisation of Martina Berto Tbk is 164B IDR (≈ $9.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Martina Berto Tbk (MBTO)?
The price-to-sales ratio of Martina Berto Tbk is 0.30 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Martina Berto Tbk (MBTO)?
Earnings per share at Martina Berto Tbk are −120.73 IDR. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Martina Berto Tbk (MBTO)?
The net margin of Martina Berto Tbk is −6.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Martina Berto Tbk (MBTO)?
The return on equity (ROE) of Martina Berto Tbk is −3.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Martina Berto Tbk (MBTO)?
On an EBIT basis the return on assets of Martina Berto Tbk is −2.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Martina Berto Tbk (MBTO)?
The operating margin of Martina Berto Tbk is 13.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Martina Berto Tbk (MBTO)?
Revenue at Martina Berto Tbk is growing +23.9% versus a year earlier (3y avg +3.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Martina Berto Tbk (MBTO)?
Earnings per share at Martina Berto Tbk are growing −98.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Martina Berto Tbk (MBTO) carry?
The net debt of Martina Berto Tbk is 155B IDR (fiscal year 2025, ≈ 10.7 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Martina Berto Tbk in the live analysis

One click puts Martina Berto Tbk on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.